• 1
    Jankowski JA, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. Gastroenterology 2002; 122: 58890.
  • 2
    Meining A, Ott R, Becker I, et al. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only – what is the clinical significance? Gut 2004; 53: 14027.
  • 3
    Cameron A, Carpenter HA. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol 1997; 92: 58691.
  • 4
    Tschanz ER. Do 40% of patients resected for Barrett esophagus with high-grade dysplasia have unsuspected adenocarcinoma? Arch Pathol Lab Med 2005; 129: 17780.
  • 5
    Sharma P, Topalovski M, Mayo MS, Weston AP. Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus. Gastrointest Endosc 2001; 54: 28993.
  • 6
    Guelrud M, Herrera I, Essenfeld H, Castro J. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 2001; 53: 55965.
  • 7
    Toyoda H, Rubio C, Befrits R, Hamamoto N, Adachi Y, Jaramillo E. Detection of intestinal metaplasia in distal esophagus and esophagogastric junction by enhanced-magnification endoscopy. Gastrointest Endosc 2004; 59: 1521.
  • 8
    Schlemper R, Riddell RH, Kato Y. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 2515.
  • 9
    Sharma P, Reker D, Falk GW, Johnston M, Weston AP, Sampliner RE. Progression of Barrett's oesophagus to high-grade dysplasia and cancer. Gastroenterology 2001; 120[5 (Suppl. 1)]: A16.
  • 10
    Van Dam J. Novel methods of enhanced endoscopic imaging. Gut 2003; 52: 1216.
  • 11
    Bruno M. Magnification endoscopy, high resolution endoscopy, and chromoscopy; towards a better optical diagnosis. Gut 2003; 52: 711.
  • 12
    Canto M, Setrakian S, Willis CA, et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 2000; 51: 56068.
  • 13
    Kiesslich R, Hahn M, Herrmann G, Jung M. Screening for specialized columnar epithelium with methylene blue: chromoendoscopy in patients with Barrett's esophagus and a normal control group. Gastrointest Endosc 2001; 53: 4752.
  • 14
    Wo J, Ray MB, Mayfield-Stokes S, et al. Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus: a preliminary study. Gastrointest Endosc 2001; 53: 4752.
  • 15
    Oliver JR, Sahay P, Dexter S, Hardie LJ. Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus. Lancet 2003; 362: 3734.
  • 16
    Lambert R, Rey JF, Sankaranarayanan R. Magnification and chromoscopy with the acetic acid test. Endoscopy 2003; 35: 43745.
  • 17
    Eloubeidi M, Provenzale D. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy. Am J Gastroenterol 1994; 94: 93743.
    Direct Link:
  • 18
    Mandal A, Playford RJ, Wicks AC. Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK. Aliment Pharmacol Ther 2003; 17: 131924.
  • 19
    Rudolph RE, Storer BE, Haggitt RC, et al. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med 2000; 132: 61220.
  • 20
    Macdonald C, Wickes AC, Playford RJ. Final results from a 10-year cohort of patients undergoing surveillance for Barrett's metaplasia; little value but major cost. BMJ 2000; 321: 125255.
  • 21
    Sharma P, McQuaid K, Dent K, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004; 127: 31030.
  • 22
    Falk G, Rice TW, Goldblum JR, Richter JE. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 1999; 49: 1706.
  • 23
    Drewitz D, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's oesophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997; 92: 21215.
  • 24
    Brown L, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002; 11: 23556.
  • 25
    Caygill C, Reed PI, Johnston BJ, Hill MJ, Ali MH, Levi S. A single centre's 20 years’ experience of columnar-lined (Barrett's) oesophagus diagnosis. Eur J Gastroenterol Hepatol 1999; 11: 13558.